MediBeacon

Saint Louis, MO · Founded 2011 · Privately Held (backing)

Developer of fluorescent tracer-agent-based systems designed to help provide a vital and actionable measurement of organ function. MediBeacon is based in Saint Louis, MO and was founded in 2011. Its last reported valuation was $300 million in Sep 2019. It has raised $111 million across 10 recorded rounds; the latest was a $16.1 million early-stage round in Aug 2023.

Last reported valuation
$300.0M
Oct 2026
Priced at
—
Total raised
$110.6M
Last round
Early Stage VC
Aug 2023
Cap table — not yet on record

MediBeacon's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of MediBeacon with a free account
  • ·The complete investor list: 16 names
  • ·Watch MediBeacon: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Frequently asked about MediBeacon

Where does MediBeacon's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across MediBeacon's 10 recorded funding rounds.